ATE126537T1 - Diagnostika für den infektiösen katzen- bauchfellentzündungsvirus. - Google Patents

Diagnostika für den infektiösen katzen- bauchfellentzündungsvirus.

Info

Publication number
ATE126537T1
ATE126537T1 AT89313684T AT89313684T ATE126537T1 AT E126537 T1 ATE126537 T1 AT E126537T1 AT 89313684 T AT89313684 T AT 89313684T AT 89313684 T AT89313684 T AT 89313684T AT E126537 T1 ATE126537 T1 AT E126537T1
Authority
AT
Austria
Prior art keywords
fipv
virus
peritentasis
diagnostics
proteins
Prior art date
Application number
AT89313684T
Other languages
English (en)
Inventor
Beverly Dale
Miles Yamanaka
William N Acree
Lloyd G Chavez
Original Assignee
Scios Nova Inc
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc, American Home Prod filed Critical Scios Nova Inc
Application granted granted Critical
Publication of ATE126537T1 publication Critical patent/ATE126537T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89313684T 1988-12-30 1989-12-29 Diagnostika für den infektiösen katzen- bauchfellentzündungsvirus. ATE126537T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29252788A 1988-12-30 1988-12-30

Publications (1)

Publication Number Publication Date
ATE126537T1 true ATE126537T1 (de) 1995-09-15

Family

ID=23125039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89313684T ATE126537T1 (de) 1988-12-30 1989-12-29 Diagnostika für den infektiösen katzen- bauchfellentzündungsvirus.

Country Status (12)

Country Link
US (2) US5780266A (de)
EP (1) EP0376744B1 (de)
JP (1) JP2903129B2 (de)
AT (1) ATE126537T1 (de)
AU (1) AU640356B2 (de)
CA (1) CA2005291C (de)
DE (1) DE68923862T2 (de)
DK (1) DK174187B1 (de)
ES (1) ES2078246T3 (de)
GR (1) GR3017770T3 (de)
IE (1) IE67650B1 (de)
NZ (1) NZ231850A (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
WO1993023423A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Canine coronavirus s gene and uses therefor
DE69233270T2 (de) * 1991-04-25 2004-09-30 Akzo Nobel N.V. Subeinheits-Impfstoff gegen Hundecoronavirus
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
JPH07504897A (ja) * 1992-02-18 1995-06-01 パーヘリオン コーポレーション ネコ感染性腹膜炎ワクチンおよび調製方法
AU678970B2 (en) * 1992-05-08 1997-06-19 Pfizer Inc. Universal coronavirus vaccine
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
RU2236678C2 (ru) * 2002-11-04 2004-09-20 Красноярская государственная медицинская академия Способ прогноза исхода перитонита средней степени тяжести по содержанию некоторых жирных кислот в лимфоцитах больных
EP1668112A4 (de) 2003-06-20 2009-04-29 Protein Sciences Corp Sars-immunogene exprimierende vektoren, solche vektoren oder expressionsprodukte davon enthaltende zusammensetzungen, verfahren und tests zur herstellung und verwendung
RU2480756C2 (ru) * 2011-02-10 2013-04-27 Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования течения послеоперационного периода у больных с перитонитом
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
JP7060324B2 (ja) 2013-12-20 2022-04-26 ザ・ブロード・インスティテュート・インコーポレイテッド ネオ抗原ワクチンによる併用療法
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
EP3234130B1 (de) 2014-12-19 2020-11-25 The Broad Institute, Inc. Verfahren zum profiling vom t-zell-rezeptor-repertoire
JP6913032B2 (ja) 2015-05-20 2021-08-04 ザ・ブロード・インスティテュート・インコーポレイテッド 共通ネオ抗原
TW202241500A (zh) 2015-06-09 2022-11-01 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
AU2017254477A1 (en) 2016-04-18 2018-11-01 Jennifer G. ABELIN Improved HLA epitope prediction
EP3574116A1 (de) 2017-01-24 2019-12-04 The Broad Institute, Inc. Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids
WO2020131586A2 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Methods for identifying neoantigens
US12394502B2 (en) 2019-10-02 2025-08-19 The General Hospital Corporation Method for predicting HLA-binding peptides using protein structural features

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796477B (en) * 1978-11-30 1981-07-29 Wellcome Found Feline infectious peritonitis vaccine
NZ192270A (en) * 1978-11-30 1983-05-31 Wellcome Found Attenuated strain of feline infectious peritonitis virus and vaccine
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
AU604682B2 (en) * 1986-02-06 1991-01-03 Cornell Research Foundation Inc. Feline infectious peritonitis vaccine
EP0264979A1 (de) * 1986-09-05 1988-04-27 Duphar International Research B.V Proteine und Peptide, wirksam wie Antigen und Impfstoffe gegen das infektiöse Peritonitisvirus der Felides (FIPV)
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes

Also Published As

Publication number Publication date
JP2903129B2 (ja) 1999-06-07
DE68923862D1 (de) 1995-09-21
DK672789A (da) 1990-07-01
ES2078246T3 (es) 1995-12-16
CA2005291A1 (en) 1990-06-30
US5780266A (en) 1998-07-14
AU4691589A (en) 1990-07-05
CA2005291C (en) 1999-01-26
JPH02291273A (ja) 1990-12-03
DE68923862T2 (de) 1996-02-08
NZ231850A (en) 1992-10-28
GR3017770T3 (en) 1996-01-31
DK672789D0 (da) 1989-12-29
DK174187B1 (da) 2002-08-26
IE894222L (en) 1990-06-30
US5811104A (en) 1998-09-22
IE67650B1 (en) 1996-04-17
EP0376744B1 (de) 1995-08-16
AU640356B2 (en) 1993-08-26
EP0376744A1 (de) 1990-07-04

Similar Documents

Publication Publication Date Title
DE68923862D1 (de) Diagnostika für den infektiösen Katzen-Bauchfellentzündungsvirus.
ATE307827T1 (de) Respiratorisches syncytialvirus; impfstoffe und diagnostische tests
ATE195076T1 (de) Verfahren zur isolierung von haemopnilus influenzae protein-e
FI861626A0 (fi) Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
FI895050A0 (fi) Diagnostiska preparat och vaccin foer mykobakterier i folkhaelso-, medicinsk och veterinaermedicinsk praxis.
FI861485A0 (fi) Producering av immunologiskt reaktiva virala proteiner.
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE3481199D1 (de) Verfahren zur gewinnung von viren bzw. virusantigenen und deren anwendung in diagnose und therapie (impfstoff).
PT87375A (pt) Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koeperfluessigkeiten und mittel zu dessen durchfuehrung
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
NO20005217D0 (no) DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion
DE69531505D1 (de) Verfahren zur zellerkennung
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
ATE199596T1 (de) Diagnostisches reagenz für hepatitis c
DE3888775D1 (de) Impfstoff für den Schutz von Katzen gegen infektiöse Katzenperitonitis.
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
DE69023140D1 (de) Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion
NO902491D0 (no) Proteiner, vaksiner og nukleinsyrer.
RU94026376A (ru) Набор для выявления хламидийной инфекции
DE3778375D1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time